期刊文献+

对青年高血压患者实施健康教育的效果评价 被引量:4

Assessment of the health education to young people suffered from hypertension
原文传递
导出
摘要 目的对青年高血压病患者实施健康教育并评价实施的效果,探讨健康教育对其血压控制及减少和延缓并发症发生、发展的作用。方法选择在专科门诊就诊的Ⅰ、Ⅱ级青年高血压病患者120例,由医生和护士、营养师组成的健康教育队伍对这些患者开展讲座、咨询、义诊等形式的健康教育,并长期跟踪随访观察。结果健康教育组的收缩压、舒张压和血脂三项,教育后较教育前均有显著下降。结论健康教育是控制高血压的前提和重要组成部分,控制高血压患者的血压可以预防重要靶器官的损害,减少心脑血管并发症发生的危险。 Objective To conduct the health education to young high-blood-pressure patients and to valuate the effect,and to explore the effect of the health education on the control of blood pressure,and the reduction and retardation of the occurrence and development of the complications.(Methods 120) young cases with grade I to II hypertension were chosen from the patients who received treatment in the specialist outpatient.Then the health educations,such as a course of lectures,free medical care and consultation and so on,were given to the patients by the health education group consisted of doctors,nurses and nutrients.Furthermore,the patients were follow-up visited and observed for a long time.Results The systolic blood pressure,diastolic blood pressure and blood-lipid after the treatment were remarkably decreased as compared to those before the treatment.Conclusions Health education for patients suffered from high blood pressure will be the premise and the most important part of the hypertension control.The hypertension control of the patients suffered from high blood pressure can prevent the injury of important target organs,and can decrease the risk of incidence of cardiovascular complications.
出处 《中华现代护理杂志》 2006年第17期1663-1664,共2页 Chinese Journal of Modern Nursing
关键词 健康教育 高血压 青年 Hypertension Health education Youth
  • 相关文献

参考文献2

二级参考文献11

  • 1[1]Wilhelmsen L,Berglund G,Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden[J]. European Heart Journal, 1986,7∶279-288.
  • 2[2]Jacobs DR, Lupker RV, Mittelmark MB, et al. Community-wide prevention strategies. Evaluation design of the Minnesota Heart Health Progran[J]. J Chronic Dis, 1986,39∶775-788.
  • 3[3]WHO European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-yera result [J]. Lancet, 1986,1∶869-872.
  • 4[4]The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High blood Pressure (JNC V) [J]. Arch Intern Med, 1993, 153(1)∶154-183.
  • 5[5]Mac Mahon S, Podgers A. Blood pressure, antihypertensive treatment and stroke risk[J]. J Hypertens, 1994,12(10)∶S5-14.
  • 6[6]Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia [J]. Lancet, 1998, 352(9143)∶1801-1807.
  • 7[7]Ambrosioni E, Bacchelli S.Clinical approach to the hypertensive patient. New guidelines[J]. Ann Ital Med Int, 1998,13(1)∶30-36.
  • 8[8]Quan A, Kerlikowske K, Gureyffier F, et al. Efficacy of treating hypertension in women[J]. J Gen Intern Med, 1999, 14(12)∶718-729.
  • 9McGill HC, Jr.McMahan CN, Zieske AW, et al. Associations of coronary heart disease risk factors with the intermediate lesion of athenninams in young.The Pathobiological Determinants of Atherosclerosis in Youth Research Group[J].Arterioscler thromb Vase Biol, 2000, 20:1998-2005.
  • 10Lonn L,Yusufs.Effects of Ramipril and Vitamin E on Atherasound Changes in patients Treated with Ramipril ang Vitamin E[J].Circulation,2001,103:919-925,.

共引文献59

同被引文献38

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部